Shopping Cart
Remove All
Your shopping cart is currently empty
Omaciclovir (ABT-091) is a selective herpesvirus herpesvirus replication inhibitor and a nucleoside analog with antiviral activity for the study of herpesvirus infections.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $149 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $29 | 10-14 weeks | 10-14 weeks |
| Description | Omaciclovir (ABT-091) is a selective herpesvirus herpesvirus replication inhibitor and a nucleoside analog with antiviral activity for the study of herpesvirus infections. |
| Targets&IC50 | MeWo VZ30:0.016 μM (EC50), MeWo VZV-32:0.015 μM (EC50), MRC5 VZV-32:0.72 μM (EC50), MeWo VZ11:0.035 μM (EC50), MeWo Emily:0.047 μM (EC50), MeWo Molly:0.048 μM (EC50), MRC5 Molly:0.62 μM (EC50) |
| In vitro | Omaciclovir is a nucleoside analog with inhibitory activity in vitro against varicella-zoster virus (VZV), herpes simplex virus types 1 and 2 (HSV-1 and HSV-2), Epstein-Barr virus, and human herpesvirus 6. Additionally, Omaciclovir demonstrates significant antiviral activity against various human herpesviruses, with half-maximal effective concentrations (EC50) of EC50=0.72 μM, EC50=0.62 μM, EC50=0.015 μM, EC50=0.048 μM, EC50=0.047 μM, EC50=0.035 μM, and EC50=0.016 μM in MRC-5 VZV-32, MRC-5 Molly, MeWo VZV-32, MeWo Molly, MeWo Emily, MeWo VZ11, and MeWo VZ30, respectively. [1] |
| In vivo | Omaciclovir has also shown efficacy in monkeys infected with simian varicella virus. [1] |
| Synonyms | H2G, H 2G, ABT-091, ABT091, ABT 091, (-)-2HM-HBG |
| Molecular Weight | 253.26 |
| Formula | C10H15N5O3 |
| Cas No. | 124265-89-0 |
| Smiles | C([C@@H](CCO)CO)N1C2=C(N=C1)C(=O)N=C(N)N2 |
| Relative Density. | 1.68g/cm3 |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 200 mg/mL (789.7 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (19.74 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.